Report post

What is the appeal of Astellas shares today?

The primary appeal to Astellas shares today is the idea that there is underappreciated growth potential in the business that will be realized over the next three to five years. Xtandi is still very much the main driver of this business, comprising more than 40% of total sales (over 42% of fiscal Q3 sales).

Does Astellas Pharma publish its annual report 2021?

Astellas Pharma : Annual Report 2021 is now available. Astellas publish its annual report as an integrated report to enable deeper stakeholder understanding of Astellas' efforts to continuously create value for sustainable growth.

Is Astellas a fair value?

Newer R&D efforts in areas like mitochondrial disorders, cell therapies, and gene therapies are further back, but hold promise as Astellas restructures around expertise-driven R&D. Five-year revenue growth of 6%-7% and long-term growth of 2%-3%, coupled with double-digit EPS growth through 2026 can support a fair value in the high-teens (ADRs).

The World's Leading Crypto Trading Platform

Get my welcome gifts